These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32762780)

  • 1. Effect of prospective audit and feedback on inpatient fluoroquinolone use and appropriateness of prescribing.
    Marek CM; Zurek KJ; Degenhardt O; Remtulla S; Teale AS; Cervera C; Hoang HL
    Infect Control Hosp Epidemiol; 2020 Dec; 41(12):1458-1460. PubMed ID: 32762780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inpatient Fluoroquinolone Stewardship Improves the Quantity and Quality of Fluoroquinolone Prescribing at Hospital Discharge: A Retrospective Analysis Among 122 Veterans Health Administration Hospitals.
    Suzuki H; Perencevich EN; Alexander B; Beck BF; Goto M; Lund BC; Nair R; Livorsi DJ
    Clin Infect Dis; 2020 Aug; 71(5):1232-1239. PubMed ID: 31562815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association of Antibiotic Stewardship With Fluoroquinolone Prescribing in Michigan Hospitals: A Multi-hospital Cohort Study.
    Vaughn VM; Gandhi T; Conlon A; Chopra V; Malani AN; Flanders SA
    Clin Infect Dis; 2019 Sep; 69(8):1269-1277. PubMed ID: 30759198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acceptability and effectiveness of antimicrobial stewardship implementation strategies on fluoroquinolone prescribing.
    Suda KJ; Clore GS; Evans CT; Reisinger HS; Kale I; Echevarria K; Sherlock SH; Perencevich EN; Goetz MB;
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1361-1368. PubMed ID: 33843527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study.
    Morales DR; Slattery J; Pinheiro L; Kurz X; Hedenmalm K
    Clin Drug Investig; 2018 Oct; 38(10):927-933. PubMed ID: 30143952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoroquinolone Therapy for the Prevention of Multidrug-Resistant Tuberculosis in Contacts. A Cost-Effectiveness Analysis.
    Fox GJ; Oxlade O; Menzies D
    Am J Respir Crit Care Med; 2015 Jul; 192(2):229-37. PubMed ID: 25915791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology.
    Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L
    New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Combination Antibiogram and Related Education on Inpatient Fluoroquinolone Prescribing Patterns for Patients With Health Care-Associated Pneumonia.
    Liang B; Wheeler JS; Blanchette LM
    Ann Pharmacother; 2016 Mar; 50(3):172-9. PubMed ID: 26783358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
    Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving benzodiazepine prescribing for elderly hospital inpatients using audit and multidisciplinary feedback.
    Elliott RA; Woodward MC; Oborne CA
    Intern Med J; 2001 Dec; 31(9):529-35. PubMed ID: 11767867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone prescribing in the United States: 1995 to 2002.
    Linder JA; Huang ES; Steinman MA; Gonzales R; Stafford RS
    Am J Med; 2005 Mar; 118(3):259-68. PubMed ID: 15745724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone prescriptions in a teaching hospital: a prospective audit.
    Pulcini C; Mondain V; Lieutier F; Mousnier A; Roger PM; Dellamonica P
    Scand J Infect Dis; 2007; 39(11-12):1013-7. PubMed ID: 17852936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient fluoroquinolone prescribing patterns before and after US FDA boxed warning.
    Bratsman A; Mathias K; Laubscher R; Grigoryan L; Rose S
    Pharmacoepidemiol Drug Saf; 2020 Jun; 29(6):701-707. PubMed ID: 32390266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a Health Care System Respiratory Fluoroquinolone Restriction Program To Alter Utilization and Impact Rates of Clostridium difficile Infection.
    Shea KM; Hobbs ALV; Jaso TC; Bissett JD; Cruz CM; Douglass ET; Garey KW
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relevance of fluoroquinolone use in Nancy's hospital. Results of the first turn].
    Desmots E; Demore B; Doco-Lecompte T; Burty C; Rabaud C; May T
    Pathol Biol (Paris); 2011 Apr; 59(2):122-6. PubMed ID: 20570055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of Fluoroquinolone Prescribing in the Long-Term Care Setting.
    Blaszczyk AT; Anderson SS; Hall RG
    J Am Geriatr Soc; 2020 Mar; 68(3):661-663. PubMed ID: 31922257
    [No Abstract]   [Full Text] [Related]  

  • 17. Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study.
    Daneman N; Chateau D; Dahl M; Zhang J; Fisher A; Sketris IS; Quail J; Marra F; Ernst P; Bugden S;
    Clin Microbiol Infect; 2020 May; 26(5):613-618. PubMed ID: 31655215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.
    Adam HJ; Hoban DJ; Gin AS; Zhanel GG
    Int J Antimicrob Agents; 2009 Jul; 34(1):82-5. PubMed ID: 19342204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
    Caterino JM; Weed SG; Espinola JA; Camargo CA
    Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of preauthorization and prospective audit and feedback system on oral antimicrobial prescription for outpatients at a children's hospital in Japan.
    Kinoshita N; Komura M; Tsuzuki S; Shoji K; Miyairi I
    J Infect Chemother; 2020 Jun; 26(6):582-587. PubMed ID: 32088130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.